Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.003
Neutral
RSI(14)
38.479
Neutral
STOCH(KDJ)(9,3,3)
26.602
Neutral
ATR(14)
0.031
Low Volatility
CCI(14)
-80.728
Neutral
Williams %R
69.388
Sell
TRIX(12,20)
-0.663
Sell
StochRSI(14)
100.000
Buy
Search
Impact Biomedical Inc
IBOAdd to Watchlist
0.430USD
0.0000.00%
Close 07-31 16:00（ET）Quotes delayed by 15 min
46.36MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
-2.27%
1 Month
-6.52%
6 Months
-12.24%
Year to Date
-14.85%
1 Year
-29.57%
Key Figures
0.431Open
0.439High
10.91KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
0.430Prev. Close
0.430Low
3.25KTurnover
LossP/E Static
3.57P/B
0.00%Div Yield TTM
-69.34%ROA
1.95052wk High
0.84Volume Ratio
-24.71MNet Profit
104.62MShares
-0.2914EPS TTM
--Beta
-168.66%ROE
0.36252wk Low
2.02%Amplitude
100.00%Gross Margin
46.36MMarket Cap
-1.19Reward/Risk
7.49%Risk Rate
TradingKey Stock Score of Impact Biomedical Inc
Currency: USD Updated: 2026-07-31Key Insights
Impact Biomedical Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 211 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Impact Biomedical Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Impact Biomedical Inc Highlights
StrengthsRisks
Impact Biomedical, Inc. is a biotechnology company engaged in discovering, developing, and patenting healthcare solutions. It discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. It has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. It also evaluates additional technologies.
Growing
The company is in a growing phase, with the latest annual income totaling USD 32.00K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 32.00K.
Undervalued
The company’s latest PE is -1.48, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 2.77M shares, increasing 42.98% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 9.78 shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Impact Biomedical Inc News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.430
Buy
MA10
0.434
Sell
MA20
0.446
Sell
MA50
0.496
Sell
MA100
0.555
Sell
MA200
0.526
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Impact Biomedical Inc Info
Impact Biomedical, Inc. is a biotechnology company engaged in discovering, developing, and patenting healthcare solutions. It discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. It has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. It also evaluates additional technologies.
Ticker SymbolIBO
CompanyImpact Biomedical Inc
CEOHeuszel (Frank D)
Websitehttps://www.impactbiomedinc.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Impact Biomedical Inc (IBO)?
The current price of Impact Biomedical Inc (IBO) is 0.43.
What is the symbol of Impact Biomedical Inc?
The ticker symbol of Impact Biomedical Inc is IBO.
What is the 52-week high of Impact Biomedical Inc?
The 52-week high of Impact Biomedical Inc is 1.95.
What is the 52-week low of Impact Biomedical Inc?
The 52-week low of Impact Biomedical Inc is 0.36.
What is the market capitalization of Impact Biomedical Inc?
The market capitalization of Impact Biomedical Inc is 45.45M.
What is the Earnings Per Share (EPS TTM) of Impact Biomedical Inc (IBO)?
The Earnings Per Share (EPS TTM) of Impact Biomedical Inc (IBO) is -0.38.